Article Details
Retrieved on: 2022-12-30 09:29:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Study Shows - Junshi Biosciences and Vigonvita Life Science's VV116 had similar results to Pfizer's drug in a trial during the Shanghai outbreak.
Article found on: www.caixinglobal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here